ArticleHealth promotion international2026
Acceptability of HIV self-testing among sexual health service providers and Two-Spirit, gay, bisexual, and queer men in Ontario, Canada.
Article in Health promotion international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
In 2020, Health Canada approved the INSTI human immunodeficiency virus (HIV) self-test. Adoption and distribution of alternative HIV testing interventions, like self-testing, are essential in meeting the United Nations 95-95-95 goals. We explored the acceptability of HIV self-testing among sexual health service providers and Two-Spirit, gay, bisexual, and queer men (2SGBQM). Between 2020 and 2021, peer researchers conducted virtual focus groups (13) and interviews (18) with providers (n = 18) and 2SGBQM (n = 38) across Ontario, Canada, and analysed data using community-based participatory research approach and reflexive thematic analysis. HIV self-testing was highly acceptable among both providers and 2SGBQM. Both groups identified 'increased access to HIV testing' as a benefit. Providers identified 'client empowerment' and 'reduced workload for providers' as other perceived benefits. 2SGBQM highlighted 'convenience' as a key benefit and rationale for self-testing, though some expressed concerns and hesitance due to 'fear of needles/blood' and 'perceptions of lower accuracy and reliability' of self-test results. Providers and 2SGBQM referred to the 'potential for missed connections to care', and 'self-harm' with positive test results as additional concerns for self-testing. Both groups suggested that first-time or inexperienced testers should be tested in-clinic, compared with experienced or regular testers who may benefit from self-testing. Participants expressed that HIV self-testing should be widely available for free, or a modest fee up to $20 CAD. Providers and 2SGBQM both found HIV self-testing highly acceptable, particularly when self-administered by experienced testers. Clinic-based testing remains important, especially for first-time testers and 2SGBQM who have concerns or hesitance regarding self-testing.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.